Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Diane Brady

Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research

Brainstorm Health 2021-Pfizer-Albert Bourla (Credit: Courtesy of Pfizer)
  • In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats. 
  • The big story: Trump’s tariff regime is open to compromises.
  • The markets: Mixed. Gains in the U.S. and Asia but gloom persists in Europe and S&P futures.
  • Analyst notes from Macquarie and Claudia Sahm on Trump and Powell, Goldman Sachs on the dollar, and Nomura on the political effect of cheap Chinese imports.
  • Plus: All the news and watercooler chat from Fortune.

Good morning. Pfizer’s Albert Bourla has become a fixture among Fortune 500 CEOs, having run the pharma giant since 2018. Yet Bourla—who trained as a veterinarian and joined Pfizer’s animal health division in 1993—considers himself a scientist first and a businessman second. As he said at a New York Academy of Sciences (NYAS) dinner earlier this week where he was being honored: “Science is the cornerstone of progress in our society.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.